Page tree

Versions Compared


  • This line was added.
  • This line was removed.
  • Formatting was changed.


All the examples shown below should be considered in the context of the information provided in the Conflicts Policy: conflicts of interest and Cochrane Reviews section of the Editorial Publishing Policy Resource

  1. A ‘commercial sponsor or source’ is defined as any for-profit manufacturer or any other for-profit source with a real or potential vested interest in the findings of a specific review.
  2. Authors who in the last 3 years have received financial support from commercial sponsors or sources with a real or potential financial interest in the findings of the review, should declare these interests at the earliest possible stage in the editorial process. Such financial support may include remuneration from a consultancy, grants, fees, fellowships, support for sabbaticals, royalties, stocks from pharmaceutical companies, advisory board membership or otherwise. In such cases, at the funding arbiter’s discretion, and only where a majority of the review authors and lead author have no relevant COIs, it may be possible for an author who has a declared interest as listed in the previous sentence to be a Cochrane review author.
  3. The ‘lead author’ is the first named author in the review byline.